GSK-239512 is a novel histamine H(3) receptor antagonist. GSK-239512 was developed for the treatment of cognitive dysfunction in neurodegenerative disorders with mild to moderate Alzheimer's disease. References: Kubo M, Kishi T, Matsunaga S, Iwata N. Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. J Alzheimers Dis. 2015;48(3):667-71. doi: 10.3233/JAD-150393. PubMed PMID: 26402104.

纯度：≥98%

CAS：720691-69-0